Published in PLoS One on September 09, 2016
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84
NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res (2012) 15.84
The diverse functions of microRNAs in animal development and disease. Dev Cell (2006) 15.62
A MicroRNA feedback circuit in midbrain dopamine neurons. Science (2007) 8.33
Modular regulatory principles of large non-coding RNAs. Nature (2012) 7.42
Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet (2009) 3.56
PGC-1α, a potential therapeutic target for early intervention in Parkinson's disease. Sci Transl Med (2010) 3.48
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
A two-stage meta-analysis identifies several new loci for Parkinson's disease. PLoS Genet (2011) 3.16
Expression Atlas update--a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments. Nucleic Acids Res (2013) 2.97
Exon arrays provide accurate assessments of gene expression. Genome Biol (2007) 2.86
Emerging roles of non-coding RNAs in brain evolution, development, plasticity and disease. Nat Rev Neurosci (2012) 2.52
ArrayExpress update--simplifying data submissions. Nucleic Acids Res (2014) 2.34
Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med (2009) 2.23
RNA-Seq: a method for comprehensive transcriptome analysis. Curr Protoc Mol Biol (2010) 2.03
Gene: a gene-centered information resource at NCBI. Nucleic Acids Res (2014) 2.00
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology. Brain (2008) 1.92
Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm (Vienna) (2004) 1.89
Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics (2006) 1.79
Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet (2005) 1.77
Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol (2008) 1.72
Effects of gender on nigral gene expression and parkinson disease. Neurobiol Dis (2007) 1.53
SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family. Neuroscience (1999) 1.52
Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol (2005) 1.34
A cross-study transcriptional analysis of Parkinson's disease. PLoS One (2009) 1.19
pS2/TFF1 interacts directly with the VWFC cysteine-rich domains of mucins. Gastroenterology (2000) 1.18
Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease. Neurogenetics (2006) 1.16
Long non-coding RNA and alternative splicing modulations in Parkinson's leukocytes identified by RNA sequencing. PLoS Comput Biol (2014) 1.15
The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis. Sci Rep (2012) 1.06
MiR-622 suppresses proliferation, invasion and migration by directly targeting activating transcription factor 2 in glioma cells. J Neurooncol (2014) 1.05
Histological changes of the dopaminergic nigrostriatal system in aging. Cell Tissue Res (2004) 1.02
Expression analysis of dopaminergic neurons in Parkinson's disease and aging links transcriptional dysregulation of energy metabolism to cell death. Acta Neuropathol (2011) 1.01
Neuronal pentraxin II is highly upregulated in Parkinson's disease and a novel component of Lewy bodies. Acta Neuropathol (2007) 1.00
The degeneration of dopamine neurons in Parkinson's disease: insights from embryology and evolution of the mesostriatocortical system. Ann N Y Acad Sci (2004) 1.00
Down-regulation of miR-622 in gastric cancer promotes cellular invasion and tumor metastasis by targeting ING1 gene. World J Gastroenterol (2011) 0.98
Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol (2002) 0.96
Epigenetics in neurodegeneration: a new layer of complexity. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.96
TIGIT predominantly regulates the immune response via regulatory T cells. J Clin Invest (2015) 0.96
Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal (2012) 0.95
Disease-modifying strategies for Parkinson's disease. Mov Disord (2015) 0.95
Neuroimmune regulation of homeostatic synaptic plasticity. Neuropharmacology (2013) 0.93
Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Front Cell Neurosci (2015) 0.92
A genetic basis for the variable effect of smoking/nicotine on Parkinson's disease. Pharmacogenomics J (2012) 0.91
Selection of novel reference genes for use in the human central nervous system: a BrainNet Europe Study. Acta Neuropathol (2012) 0.90
Gene expression profiling of embryonic human neural stem cells and dopaminergic neurons from adult human substantia nigra. PLoS One (2011) 0.90
TRAM (Transcriptome Mapper): database-driven creation and analysis of transcriptome maps from multiple sources. BMC Genomics (2011) 0.90
Genetic basis of Parkinson's disease: inheritance, penetrance, and expression. Appl Clin Genet (2011) 0.90
Role of microRNAs in the regulation of innate immune cells under neuroinflammatory conditions. Curr Opin Pharmacol (2015) 0.89
Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol (2011) 0.89
Levetiracetam reverses synaptic deficits produced by overexpression of SV2A. PLoS One (2011) 0.85
Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats. Brain Behav (2012) 0.84
Linkage analysis of juvenile parkinsonism to tyrosine hydroxylase gene locus on chromosome 11. Neurology (1991) 0.83
The genetics of Parkinson's disease. Br Med Bull (2015) 0.82
Review: Parkinson's disease: from synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol (2016) 0.81
A quantitative transcriptome reference map of the normal human brain. Neurogenetics (2014) 0.81
Relevance of α-defensins (HNP1-3) and defensin β-1 in diabetes. World J Gastroenterol (2014) 0.81
Trefoil factor family peptides TFF1 and TFF3 in the nervous tissues of developing mouse embryo. Bosn J Basic Med Sci (2015) 0.80
Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS). BMC Med Genomics (2014) 0.79
A quantitative transcriptome reference map of the normal human hippocampus. Hippocampus (2015) 0.79
Loss of angiotensin II receptor expression in dopamine neurons in Parkinson's disease correlates with pathological progression and is accompanied by increases in Nox4- and 8-OH guanosine-related nucleic acid oxidation and caspase-3 activation. Acta Neuropathol Commun (2015) 0.79
Adaptive preconditioning in neurological diseases - therapeutic insights from proteostatic perturbations. Brain Res (2016) 0.79
Chromosome 5 and Parkinson disease. Eur J Hum Genet (2006) 0.77
Peripheral α-defensins 1 and 2 are elevated in Alzheimer's disease. J Alzheimers Dis (2015) 0.77
Gene Expression in HIV-Associated Neurocognitive Disorders: A Meta-Analysis. J Acquir Immune Defic Syndr (2015) 0.77